Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ALB | P02768 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7929990 | 0.77 | TTR (0.44) | TTRTDP1ALBMEN1LMNA | |
| SCHEMBL22991560 | 0.75 | TTR (0.42) | TTRTDP1ALBMEN1LMNA | |
| SCHEMBL22991645 | 0.71 | TTR (0.42) | TTRTDP1ALBMEN1LMNA | |
| SCHEMBL69776 | 0.69 | TTR (0.56) | TTRTDP1ALBMEN1LMNA | |
| SCHEMBL25836509 | 0.69 | APP (0.30) | — | |
| SCHEMBL25836512 | 0.68 | TTR (0.34) | TTR | |
| SCHEMBL25836502 | 0.68 | TTR (0.56) | TTRALBMEN1LMNAHTT | |
| SCHEMBL25836511 | 0.68 | APP (0.30) | — | |
| SCHEMBL12817414 | 0.65 | TTR (0.50) | TTRTDP1ALBMEN1LMNA | |
| SCHEMBL7929422 | 0.64 | TTR (0.50) | TTRTDP1ALBMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11702498-B2 | Radiopaque polymers | BIOCOMPATIBLES UK LIMITED | 2023-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11702498-B2 | Radiopaque polymers | OXER1, NR5A1, AQP1 | TTR 3572/4885TDP1 1343/4885ALB 3797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.